Krishana Phoschem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:02 pm

Quick Insight

Krishana Phoschem Ltd, operating in the fertiliser sector, currently trades at ₹524, reflecting a market capitalization of ₹3,176 crore and a price-to-earnings (P/E) ratio of 31.5. The company boasts a robust return on equity (ROE) of 25.3% and a return on capital employed (ROCE) of 21.8%, indicating efficient use of capital. Despite having a relatively high price-to-book value (P/BV) of 5.02x, the operating profit margin (OPM) stands at a modest 12%, while net profits total ₹87 crore. With promoters holding 71.03% and a manageable interest coverage ratio (ICR) of 3.54x, the company appears stable. However, the high cash conversion cycle (CCC) of 154 days and substantial borrowings of ₹376 crore warrant caution. Investors should weigh these factors carefully, as the solid fundamentals must

Competitors of Krishana Phoschem Ltd

All Competitor Stocks of Krishana Phoschem Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:10 pm

Below is a detailed analysis of the quarterly data for Krishana Phoschem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 396.00 Cr., marking a decrease of 77.00 Cr..
• For Expenses, as of Jun 2025, the value is 330.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 417.00 Cr. (Mar 2025) to 330.00 Cr., marking a decrease of 87.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 10.00 Cr..
• For OPM %, as of Jun 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 17.00%, marking an increase of 5.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 51.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 51.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 40.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Mar 2025) to 40.00%, marking an increase of 10.00%.
• For Net Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 5.05. The value appears to be declining and may need further review. It has decreased from 5.43 (Mar 2025) to 5.05, marking a decrease of 0.38.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:29 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:53 pm

Below is a detailed analysis of the balance sheet data for Krishana Phoschem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 62.00 Cr..
• For Reserves, as of Mar 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 239.00 Cr. (Mar 2024) to 322.00 Cr., marking an increase of 83.00 Cr..
• For Borrowings, as of Mar 2025, the value is 376.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 435.00 Cr. (Mar 2024) to 376.00 Cr., marking a decrease of 59.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 167.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,036.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 845.00 Cr. (Mar 2024) to 1,036.00 Cr., marking an increase of 191.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 295.00 Cr.. The value appears to be declining and may need further review. It has decreased from 322.00 Cr. (Mar 2024) to 295.00 Cr., marking a decrease of 27.00 Cr..
• For CWIP, as of Mar 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 78.00 Cr., marking an increase of 35.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 664.00 Cr.. The value appears strong and on an upward trend. It has increased from 479.00 Cr. (Mar 2024) to 664.00 Cr., marking an increase of 185.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,036.00 Cr.. The value appears strong and on an upward trend. It has increased from 845.00 Cr. (Mar 2024) to 1,036.00 Cr., marking an increase of 191.00 Cr..

However, the Borrowings (376.00 Cr.) are higher than the Reserves (322.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Krishana Phoschem Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 6.54. This value is within the healthy range. It has decreased from 8.80 (Mar 23) to 6.54, marking a decrease of 2.26.
• For Diluted EPS (Rs.), as of Mar 24, the value is 6.54. This value is within the healthy range. It has decreased from 8.65 (Mar 23) to 6.54, marking a decrease of 2.11.
• For Cash EPS (Rs.), as of Mar 24, the value is 12.07. This value is within the healthy range. It has increased from 11.46 (Mar 23) to 12.07, marking an increase of 0.61.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 48.62. It has decreased from 84.69 (Mar 23) to 48.62, marking a decrease of 36.07.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 48.62. It has decreased from 84.69 (Mar 23) to 48.62, marking a decrease of 36.07.
• For Dividend / Share (Rs.), as of Mar 24, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 149.43. It has increased from 104.43 (Mar 23) to 149.43, marking an increase of 45.00.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 21.02. This value is within the healthy range. It has increased from 17.61 (Mar 23) to 21.02, marking an increase of 3.41.
• For PBIT / Share (Rs.), as of Mar 24, the value is 15.50. This value is within the healthy range. It has increased from 14.80 (Mar 23) to 15.50, marking an increase of 0.70.
• For PBT / Share (Rs.), as of Mar 24, the value is 9.55. This value is within the healthy range. It has decreased from 12.60 (Mar 23) to 9.55, marking a decrease of 3.05.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 6.54. This value is within the healthy range. It has decreased from 8.65 (Mar 23) to 6.54, marking a decrease of 2.11.
• For PBDIT Margin (%), as of Mar 24, the value is 14.06. This value is within the healthy range. It has decreased from 16.86 (Mar 23) to 14.06, marking a decrease of 2.80.
• For PBIT Margin (%), as of Mar 24, the value is 10.37. This value is within the healthy range. It has decreased from 14.17 (Mar 23) to 10.37, marking a decrease of 3.80.
• For PBT Margin (%), as of Mar 24, the value is 6.39. This value is below the healthy minimum of 10. It has decreased from 12.06 (Mar 23) to 6.39, marking a decrease of 5.67.
• For Net Profit Margin (%), as of Mar 24, the value is 4.37. This value is below the healthy minimum of 5. It has decreased from 8.28 (Mar 23) to 4.37, marking a decrease of 3.91.
• For Return on Networth / Equity (%), as of Mar 24, the value is 13.45. This value is below the healthy minimum of 15. It has increased from 10.21 (Mar 23) to 13.45, marking an increase of 3.24.
• For Return on Capital Employeed (%), as of Mar 24, the value is 19.62. This value is within the healthy range. It has increased from 10.73 (Mar 23) to 19.62, marking an increase of 8.89.
• For Return On Assets (%), as of Mar 24, the value is 4.78. This value is below the healthy minimum of 5. It has increased from 4.59 (Mar 23) to 4.78, marking an increase of 0.19.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.52. This value is within the healthy range. It has decreased from 0.55 (Mar 23) to 0.52, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.45. This value exceeds the healthy maximum of 1. It has increased from 1.06 (Mar 23) to 1.45, marking an increase of 0.39.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.29. It has increased from 0.70 (Mar 23) to 1.29, marking an increase of 0.59.
• For Current Ratio (X), as of Mar 24, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.36 (Mar 23) to 1.33, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 23) to 0.92, marking an increase of 0.27.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.61. This value is within the healthy range. It has increased from 1.86 (Mar 23) to 4.61, marking an increase of 2.75.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 3.82. This value is below the healthy minimum of 20. It has decreased from 5.54 (Mar 23) to 3.82, marking a decrease of 1.72.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 2.07. This value is below the healthy minimum of 20. It has decreased from 4.18 (Mar 23) to 2.07, marking a decrease of 2.11.
• For Earning Retention Ratio (%), as of Mar 24, the value is 96.18. This value exceeds the healthy maximum of 70. It has increased from 94.46 (Mar 23) to 96.18, marking an increase of 1.72.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 97.93. This value exceeds the healthy maximum of 70. It has increased from 95.82 (Mar 23) to 97.93, marking an increase of 2.11.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.54. This value is within the healthy range. It has decreased from 7.98 (Mar 23) to 3.54, marking a decrease of 4.44.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.10. This value is below the healthy minimum of 3. It has decreased from 4.92 (Mar 23) to 2.10, marking a decrease of 2.82.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,938.86. It has increased from 1,779.52 (Mar 23) to 1,938.86, marking an increase of 159.34.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.10. This value is within the healthy range. It has decreased from 5.51 (Mar 23) to 2.10, marking a decrease of 3.41.
• For EV / EBITDA (X), as of Mar 24, the value is 14.92. This value is within the healthy range. It has decreased from 32.69 (Mar 23) to 14.92, marking a decrease of 17.77.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.63. This value is within the healthy range. It has decreased from 4.66 (Mar 23) to 1.63, marking a decrease of 3.03.
• For Retention Ratios (%), as of Mar 24, the value is 96.17. This value exceeds the healthy maximum of 70. It has increased from 94.45 (Mar 23) to 96.17, marking an increase of 1.72.
• For Price / BV (X), as of Mar 24, the value is 5.02. This value exceeds the healthy maximum of 3. It has decreased from 5.74 (Mar 23) to 5.02, marking a decrease of 0.72.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.63. This value is within the healthy range. It has decreased from 4.66 (Mar 23) to 1.63, marking a decrease of 3.03.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness